acetylglucosamine has been researched along with sb 239063 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, M; Che, P; Davis, ME; Gray, WD; Murthy, N; Ning, X | 1 |
Levit, RD; Taylor, WR | 1 |
2 other study(ies) available for acetylglucosamine and sb 239063
Article | Year |
---|---|
N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Drug Carriers; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines | 2011 |
A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational o
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Compounding; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines; Regeneration | 2011 |